Literature DB >> 28729170

How Do Pain, Fatigue, Depressive, and Cognitive Symptoms Relate to Well-Being and Social and Physical Functioning in the Daily Lives of Individuals With Multiple Sclerosis?

Anna L Kratz1, Tiffany J Braley2, Emily Foxen-Craft3, Eric Scott4, John F Murphy5, Susan L Murphy6.   

Abstract

OBJECTIVE: To examine the relative association between daily change in pain, fatigue, depressed mood, and cognitive function and 4 outcomes-positive affect and well-being, ability to participate in social roles and activities, upper extremity (UE) functioning, and lower extremity (LE) functioning.
DESIGN: Data analysis, multilevel mixed modeling.
SETTING: General community. PARTICIPANTS: Ambulatory adults (N=102) with multiple sclerosis.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: Customized short-forms of the Quality of Life in Neurological Disorders positive affect and well-being, UE functioning, and LE functioning item banks and the Patient-Reported Outcomes Measurement Information System ability to participate in social roles and activities item bank adapted for daily use and administered as end-of-day diaries.
RESULTS: Above and beyond the effects of demographic and clinical covariates, daily pain was associated with 3 of the 4 outcomes; days of higher than usual pain were related to lower same-day social participation (unstandardized β, B=-1.00; P=.002), UE functioning (B=-1.04; P=.01), and LE functioning (B=-.71; P=.04). Daily fatigue and depressed mood were independently related to daily positive affect and well-being; days of worse fatigue (B=-.54; P=.006) and depressed mood (B=-1.17; P<.0001) were related to lower same-day well-being.
CONCLUSIONS: The results indicate the role of fluctuations in symptoms in daily functioning and quality of life of individuals with multiple sclerosis. Daily increases in pain intensity are related to social and physical functioning, whereas increases in fatigue and depressed mood are related to lower daily well-being. Findings implicate a person-centered approach to monitoring and treating symptoms.
Copyright © 2017 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ecological momentary assessment; Mental health; Multiple sclerosis; Pain; Rehabilitation; Social participation

Mesh:

Year:  2017        PMID: 28729170      PMCID: PMC5660943          DOI: 10.1016/j.apmr.2017.07.004

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  42 in total

1.  Patient non-compliance with paper diaries.

Authors:  Arthur A Stone; Saul Shiffman; Joseph E Schwartz; Joan E Broderick; Michael R Hufford
Journal:  BMJ       Date:  2002-05-18

Review 2.  Rehabilitation care and outcomes from the patient's perspective.

Authors:  A M Kramer
Journal:  Med Care       Date:  1997-06       Impact factor: 2.983

Review 3.  Multiple sclerosis-associated fatigue.

Authors:  Lauren B Krupp; Dana J Serafin; Christopher Christodoulou
Journal:  Expert Rev Neurother       Date:  2010-09       Impact factor: 4.618

4.  Cognitive Impairment and Community Integration Outcomes in Individuals Living With Multiple Sclerosis.

Authors:  Abbey J Hughes; Narineh Hartoonian; Brett Parmenter; Jodie K Haselkorn; Jesus F Lovera; Dennis Bourdette; Aaron P Turner
Journal:  Arch Phys Med Rehabil       Date:  2015-07-17       Impact factor: 3.966

5.  Brain atrophy and lesion load as explaining parameters for cognitive impairment in multiple sclerosis.

Authors:  R H C Lazeron; J B Boringa; M Schouten; B M J Uitdehaag; E Bergers; J Lindeboom; M I Eikelenboom; P H Scheltens; F Barkhof; C H Polman
Journal:  Mult Scler       Date:  2005-10       Impact factor: 6.312

6.  Pain Acceptance Decouples the Momentary Associations Between Pain, Pain Interference, and Physical Activity in the Daily Lives of People With Chronic Pain and Spinal Cord Injury.

Authors:  Anna L Kratz; Dawn M Ehde; Charles H Bombardier; Claire Z Kalpakjian; Robin A Hanks
Journal:  J Pain       Date:  2016-12-02       Impact factor: 5.820

Review 7.  Fatigue in multiple sclerosis.

Authors:  L B Krupp; C Christodoulou
Journal:  Curr Neurol Neurosci Rep       Date:  2001-05       Impact factor: 5.081

8.  Physical activity and quality of life in multiple sclerosis: intermediary roles of disability, fatigue, mood, pain, self-efficacy and social support.

Authors:  Robert W Motl; Edward McAuley; Erin M Snook; Rachael C Gliottoni
Journal:  Psychol Health Med       Date:  2009-01       Impact factor: 2.423

9.  Cross-Sectional Examination of the Associations Between Symptoms, Community Integration, and Mental Health in Multiple Sclerosis.

Authors:  Anna L Kratz; Dawn M Ehde; Marisol A Hanley; Mark P Jensen; Travis L Osborne; George H Kraft
Journal:  Arch Phys Med Rehabil       Date:  2015-10-31       Impact factor: 3.966

10.  Depression in multiple sclerosis.

Authors:  S L Minden; J Orav; P Reich
Journal:  Gen Hosp Psychiatry       Date:  1987-11       Impact factor: 3.238

View more
  16 in total

1.  Testing of Journal Writing for Symptom Concordance in Adults with Multiple Sclerosis.

Authors:  Pamela Newland; B Ann Bettencourt; Sarah Schares; Verna Hendricks-Ferguson
Journal:  Int J MS Care       Date:  2021-01-21

2.  How Do Fluctuations in Pain, Fatigue, Anxiety, Depressed Mood, and Perceived Cognitive Function Relate to Same-Day Social Participation in Individuals With Spinal Cord Injury?

Authors:  Duygu Kuzu; Jonathan P Troost; Noelle E Carlozzi; Dawn M Ehde; Ivan R Molton; Anna L Kratz
Journal:  Arch Phys Med Rehabil       Date:  2021-08-27       Impact factor: 4.060

3.  Psychometric properties of the spinal cord injury-quality of life (SCI-QOL) Resilience item bank in a sample with spinal cord injury and chronic pain.

Authors:  Duygu Kuzu; Michael A Kallen; Claire Z Kalpakjian; Anna L Kratz
Journal:  Qual Life Res       Date:  2021-09-20       Impact factor: 3.440

4.  Pain, Fatigue, and Cognitive Symptoms Are Temporally Associated Within but Not Across Days in Multiple Sclerosis.

Authors:  Anna L Kratz; Susan L Murphy; Tiffany J Braley
Journal:  Arch Phys Med Rehabil       Date:  2017-07-18       Impact factor: 3.966

5.  Ecological Momentary Assessment of Pain, Fatigue, Depressive, and Cognitive Symptoms Reveals Significant Daily Variability in Multiple Sclerosis.

Authors:  Anna L Kratz; Susan L Murphy; Tiffany J Braley
Journal:  Arch Phys Med Rehabil       Date:  2017-07-18       Impact factor: 3.966

6.  Daily Temporal Associations Between Physical Activity and Symptoms in Multiple Sclerosis.

Authors:  Anna L Kratz; Nora E Fritz; Tiffany J Braley; Eric L Scott; Emily Foxen-Craft; Susan L Murphy
Journal:  Ann Behav Med       Date:  2019-01-01

7.  Fatigue and Its Association With Social Participation, Functioning, and Quality of Life in Systemic Sclerosis.

Authors:  Susan L Murphy; Anna L Kratz; Daniel Whibley; Janet L Poole; Dinesh Khanna
Journal:  Arthritis Care Res (Hoboken)       Date:  2021-02-05       Impact factor: 4.794

8.  Family Functioning and Multiple Sclerosis: Study Protocol of a Multicentric Italian Project.

Authors:  Marialaura Di Tella; Virginia Perutelli; Giuseppina Miele; Luigi Lavorgna; Simona Bonavita; Stefania Federica De Mercanti; Lidia Mislin Streito; Marinella Clerico; Lorys Castelli
Journal:  Front Psychol       Date:  2021-06-09

9.  Integrated Cognitive and Neuromotor Rehabilitation in Multiple Sclerosis: A Pragmatic Study.

Authors:  Anna M Barbarulo; Giacomo Lus; Elisabetta Signoriello; Luigi Trojano; Dario Grossi; Mariateresa Esposito; Teresa Costabile; Roberta Lanzillo; Francesco Saccà; Vincenzo Brescia Morra; Giovannina Conchiglia
Journal:  Front Behav Neurosci       Date:  2018-09-05       Impact factor: 3.558

10.  Evaluating the feasibility and preliminary efficacy of a Cognitive Occupation-Based programme for people with Multiple Sclerosis (COB-MS): protocol for a feasibility cluster-randomised controlled trial.

Authors:  Christopher P Dwyer; Alberto Alvarez-Iglesias; Robert Joyce; Timothy J Counihan; Dympna Casey; Sinéad M Hynes
Journal:  Trials       Date:  2020-03-17       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.